| UniProt ID | RUFY1_HUMAN | |
|---|---|---|
| UniProt AC | Q96T51 | |
| Protein Name | RUN and FYVE domain-containing protein 1 | |
| Gene Name | RUFY1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 708 | |
| Subcellular Localization |
Cytoplasm. Early endosome membrane Peripheral membrane protein. |
|
| Protein Description | Binds phospholipid vesicles containing phosphatidylinositol 3-phosphate and participates in early endosomal trafficking.. | |
| Protein Sequence | MADREGGCAAGRGRELEPELEPGPGPGSALEPGEEFEIVDRSQLPGPGDLRSATRPRAAEGWSAPILTLARRATGNLSASCGSALRAAAGLGGGDSGDGTARAASKCQMMEERANLMHMMKLSIKVLLQSALSLGRSLDADHAPLQQFFVVMEHCLKHGLKVKKSFIGQNKSFFGPLELVEKLCPEASDIATSVRNLPELKTAVGRGRAWLYLALMQKKLADYLKVLIDNKHLLSEFYEPEALMMEEEGMVIVGLLVGLNVLDANLCLKGEDLDSQVGVIDFSLYLKDVQDLDGGKEHERITDVLDQKNYVEELNRHLSCTVGDLQTKIDGLEKTNSKLQEELSAATDRICSLQEEQQQLREQNELIRERSEKSVEITKQDTKVELETYKQTRQGLDEMYSDVWKQLKEEKKVRLELEKELELQIGMKTEMEIAMKLLEKDTHEKQDTLVALRQQLEEVKAINLQMFHKAQNAESSLQQKNEAITSFEGKTNQVMSSMKQMEERLQHSERARQGAEERSHKLQQELGGRIGALQLQLSQLHEQCSSLEKELKSEKEQRQALQRELQHEKDTSSLLRMELQQVEGLKKELRELQDEKAELQKICEEQEQALQEMGLHLSQSKLKMEDIKEVNQALKGHAWLKDDEATHCRQCEKEFSISRRKHHCRNCGHIFCNTCSSNELALPSYPKPVRVCDSCHTLLLQRCSSTAS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Methylation | EGGCAAGRGRELEPE CCCCCCCCCCCCCCC | 35.95 | 80700713 | |
| 14 | Methylation | GCAAGRGRELEPELE CCCCCCCCCCCCCCC | 43.92 | 9857955 | |
| 42 | Phosphorylation | EFEIVDRSQLPGPGD CEEEECHHHCCCCCC | 31.44 | 24300666 | |
| 52 | Phosphorylation | PGPGDLRSATRPRAA CCCCCCCCCCCCCCC | 41.09 | 22210691 | |
| 54 | Phosphorylation | PGDLRSATRPRAAEG CCCCCCCCCCCCCCC | 42.31 | 22210691 | |
| 63 | Phosphorylation | PRAAEGWSAPILTLA CCCCCCCCCCHHHHH | 34.72 | 28857561 | |
| 63 (in isoform 2) | Ubiquitination | - | 34.72 | 21906983 | |
| 68 | Phosphorylation | GWSAPILTLARRATG CCCCCHHHHHHHHHC | 21.06 | 24719451 | |
| 74 | Phosphorylation | LTLARRATGNLSASC HHHHHHHHCCCCHHH | 25.45 | 23401153 | |
| 78 | Phosphorylation | RRATGNLSASCGSAL HHHHCCCCHHHHHHH | 23.33 | 29978859 | |
| 80 | Phosphorylation | ATGNLSASCGSALRA HHCCCCHHHHHHHHH | 18.68 | 29978859 | |
| 83 | Phosphorylation | NLSASCGSALRAAAG CCCHHHHHHHHHHCC | 28.58 | 23684312 | |
| 96 | Phosphorylation | AGLGGGDSGDGTARA CCCCCCCCCCCHHHH | 41.90 | 21815630 | |
| 100 | Phosphorylation | GGDSGDGTARAASKC CCCCCCCHHHHHHHH | 20.08 | 28857561 | |
| 123 | Phosphorylation | LMHMMKLSIKVLLQS HHHHHHHHHHHHHHH | 18.16 | - | |
| 164 | Ubiquitination | KHGLKVKKSFIGQNK HHCCCCCHHHCCCCC | 54.29 | - | |
| 165 | Phosphorylation | HGLKVKKSFIGQNKS HCCCCCHHHCCCCCC | 19.17 | 23401153 | |
| 171 (in isoform 3) | Ubiquitination | - | 40.53 | 21906983 | |
| 171 (in isoform 1) | Ubiquitination | - | 40.53 | 21906983 | |
| 171 | Ubiquitination | KSFIGQNKSFFGPLE HHHCCCCCCCCCHHH | 40.53 | 21906983 | |
| 172 | Phosphorylation | SFIGQNKSFFGPLEL HHCCCCCCCCCHHHH | 33.10 | 28857561 | |
| 182 | Ubiquitination | GPLELVEKLCPEASD CHHHHHHHHCCCHHH | 48.16 | - | |
| 184 | S-nitrosylation | LELVEKLCPEASDIA HHHHHHHCCCHHHHH | 4.19 | 2212679 | |
| 188 | Phosphorylation | EKLCPEASDIATSVR HHHCCCHHHHHHHHH | 28.08 | - | |
| 192 | Phosphorylation | PEASDIATSVRNLPE CCHHHHHHHHHCCHH | 28.26 | 28857561 | |
| 193 | Phosphorylation | EASDIATSVRNLPEL CHHHHHHHHHCCHHH | 15.28 | 28857561 | |
| 200 (in isoform 2) | Ubiquitination | - | 5.88 | 21906983 | |
| 225 | "N6,N6-dimethyllysine" | KKLADYLKVLIDNKH HHHHHHHHHHHCCHH | 28.85 | - | |
| 225 | Methylation | KKLADYLKVLIDNKH HHHHHHHHHHHCCHH | 28.85 | 23644510 | |
| 282 (in isoform 2) | Ubiquitination | - | 3.59 | 21906983 | |
| 308 (in isoform 1) | Ubiquitination | - | 50.33 | 21906983 | |
| 308 (in isoform 3) | Ubiquitination | - | 50.33 | 21906983 | |
| 308 | Ubiquitination | ITDVLDQKNYVEELN HHHHHCCCCHHHHHH | 50.33 | 21906983 | |
| 310 | Phosphorylation | DVLDQKNYVEELNRH HHHCCCCHHHHHHHH | 19.10 | 27174698 | |
| 319 | Phosphorylation | EELNRHLSCTVGDLQ HHHHHHCCCCHHHHH | 11.13 | 29978859 | |
| 321 | Phosphorylation | LNRHLSCTVGDLQTK HHHHCCCCHHHHHHH | 24.93 | 29978859 | |
| 338 | Ubiquitination | GLEKTNSKLQEELSA HHHHHCHHHHHHHHH | 57.15 | - | |
| 344 | Phosphorylation | SKLQEELSAATDRIC HHHHHHHHHHHHHHH | 21.09 | - | |
| 347 | Phosphorylation | QEELSAATDRICSLQ HHHHHHHHHHHHHHH | 26.06 | - | |
| 349 | Methylation | ELSAATDRICSLQEE HHHHHHHHHHHHHHH | 27.71 | 115492999 | |
| 352 | Phosphorylation | AATDRICSLQEEQQQ HHHHHHHHHHHHHHH | 30.62 | - | |
| 355 (in isoform 3) | Phosphorylation | - | 64.17 | 21902226 | |
| 371 | O-linked_Glycosylation | NELIRERSEKSVEIT HHHHHHHHHHHHEEE | 44.62 | 30379171 | |
| 374 | Phosphorylation | IRERSEKSVEITKQD HHHHHHHHHEEECCC | 22.41 | 28857561 | |
| 379 | Acetylation | EKSVEITKQDTKVEL HHHHEEECCCCCCHH | 52.41 | 20167786 | |
| 389 | Phosphorylation | TKVELETYKQTRQGL CCCHHHHHHHHHHHH | 7.54 | 22817900 | |
| 390 (in isoform 1) | Ubiquitination | - | 53.25 | 21906983 | |
| 390 | Ubiquitination | KVELETYKQTRQGLD CCHHHHHHHHHHHHH | 53.25 | 2190698 | |
| 400 | Phosphorylation | RQGLDEMYSDVWKQL HHHHHHHHHHHHHHH | 10.32 | 28796482 | |
| 401 | Phosphorylation | QGLDEMYSDVWKQLK HHHHHHHHHHHHHHH | 25.11 | 28796482 | |
| 445 | Ubiquitination | LEKDTHEKQDTLVAL HHCCCHHHHHHHHHH | 45.96 | - | |
| 460 | Ubiquitination | RQQLEEVKAINLQMF HHHHHHHHHHCHHHH | 46.99 | - | |
| 466 | Sulfoxidation | VKAINLQMFHKAQNA HHHHCHHHHHHHHCH | 4.24 | 30846556 | |
| 469 | Ubiquitination | INLQMFHKAQNAESS HCHHHHHHHHCHHHH | 40.16 | - | |
| 480 | Ubiquitination | AESSLQQKNEAITSF HHHHHHHHHHHHHHH | 43.74 | - | |
| 486 | Phosphorylation | QKNEAITSFEGKTNQ HHHHHHHHHCHHHHH | 18.39 | 25159151 | |
| 490 | Ubiquitination | AITSFEGKTNQVMSS HHHHHCHHHHHHHHH | 36.78 | - | |
| 491 | Phosphorylation | ITSFEGKTNQVMSSM HHHHCHHHHHHHHHH | 41.56 | 29759185 | |
| 499 | Ubiquitination | NQVMSSMKQMEERLQ HHHHHHHHHHHHHHH | 48.73 | - | |
| 521 | Ubiquitination | GAEERSHKLQQELGG HHHHHHHHHHHHHHH | 49.60 | - | |
| 545 | Phosphorylation | SQLHEQCSSLEKELK HHHHHHHHHHHHHHH | 37.34 | 26437602 | |
| 546 | Phosphorylation | QLHEQCSSLEKELKS HHHHHHHHHHHHHHH | 48.45 | 26437602 | |
| 555 | Methylation | EKELKSEKEQRQALQ HHHHHHHHHHHHHHH | 67.26 | 23644510 | |
| 569 | Ubiquitination | QRELQHEKDTSSLLR HHHHHHHCCHHHHHH | 65.27 | - | |
| 573 | Phosphorylation | QHEKDTSSLLRMELQ HHHCCHHHHHHHHHH | 33.25 | 24719451 | |
| 618 | Phosphorylation | QEMGLHLSQSKLKME HHCCHHHCCCCCCHH | 22.97 | 17525332 | |
| 620 | Phosphorylation | MGLHLSQSKLKMEDI CCHHHCCCCCCHHHH | 36.26 | 30278072 | |
| 621 | Ubiquitination | GLHLSQSKLKMEDIK CHHHCCCCCCHHHHH | 44.48 | - | |
| 635 | Ubiquitination | KEVNQALKGHAWLKD HHHHHHHCCCCCCCC | 52.22 | - | |
| 641 | Ubiquitination | LKGHAWLKDDEATHC HCCCCCCCCCCCCCH | 53.05 | - | |
| 674 | Phosphorylation | CGHIFCNTCSSNELA CCCEEECCCCCCCCC | 18.23 | 28857561 | |
| 676 | Phosphorylation | HIFCNTCSSNELALP CEEECCCCCCCCCCC | 33.87 | 28857561 | |
| 677 | Phosphorylation | IFCNTCSSNELALPS EEECCCCCCCCCCCC | 36.15 | 28857561 | |
| 684 | Phosphorylation | SNELALPSYPKPVRV CCCCCCCCCCCCEEE | 55.72 | 24719451 | |
| 694 | Phosphorylation | KPVRVCDSCHTLLLQ CCEEECCCCHHHHHH | 11.59 | 28857561 | |
| 697 | Phosphorylation | RVCDSCHTLLLQRCS EECCCCHHHHHHHHH | 24.35 | 28857561 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RUFY1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RUFY1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-618, AND MASSSPECTROMETRY. | |
| "Interaction between tyrosine kinase Etk and a RUN-domain and FYVE-domain containing protein RUFY1. A possible role of Etk in regulationof vesicle trafficking."; Yang J., Kim O., Wu J., Qiu Y.; J. Biol. Chem. 277:30219-30226(2002). Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 7-708 (ISOFORM 1), TISSUE SPECIFICITY,SUBCELLULAR LOCATION, INTERACTION WITH BMX, PHOSPHORYLATION AT TYR-389AND TYR-400, AND MUTAGENESIS OF TYR-389 AND TYR-400. | |